FDA Adverse Event Other Summary report: N

KRYPTONITE-X RADIOPAQUE LIQUID BONE COMPLEX

MDR report key: 1652374 · Received April 5, 2010

Report

Report Number
1226001-2010-00012
Event Type
Other
Date Received
April 5, 2010
Date of Event
December 14, 2009
Report Date
March 22, 2010
Manufacturer
DOCTOR'S RESEARCH GROUP, INC.
Product Code
GXP
PMA / PMN Number
K091382
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THERE ARE SEVERAL FACTORS THAT MAY HAVE PLAYED A ROLE IN NOT ALLOWING THE KRYPTONITE-X MATERIAL TO FULLY HARDEN, INCLUDING BUT NOT LIMITED TO; INSUFFICIENT OR IMPROPER SITE PREPARATION, TOO MUCH BLOOD WITHIN SURGICAL SITE, OR IMPROPER MIXING. FOLLOW-UP INFORMATION INDICATED THAT KRYPTONITE-X WAS IMPLANTED INTO A SITE WHICH WAS BLOODY. IT WAS ADDITIONALLY INDICATED BY THE SURGEON THAT IMPROPER SITE PREPARATION, AS WELL AS, THIS BEING HIS FIRST CASE MAY HAVE ALSO CONTRIBUTED TO THIS EVENT. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, IT WILL BE SUBMITTED IN A SUPPLEMENTAL REPORT. THE IDENTIFIED PRODUCT AND PRODUCT CODE IS DESIGNATED FOR EXPORT ONLY.

Description of Event or Problem · 1

A PATIENT UNDERWENT A CRANIOTOMY ON (B)(6) 2009, WITHOUT NOTED ISSUES. A REVISION SURGERY WAS LATER PERFORMED IN (B)(6) 2009 DUE TO THE PATIENT PRESENTING WITH PURULENT PHLOGOSIS ALONG THE SCAR, IN CORRESPONDENCE WITH THE HOLES PRODUCED BY THE CRANIOTOMY FILLED WITH KRYPTONITE-X MATERIAL. THE KRYPTONITE-X MATERIAL WAS REMOVED USING BONE NIPPERS AND WAS FOUND TO NOT BE COMPLETELY SOLID, BUT STILL SOMEWHAT ELASTIC. THE KRYPTONITE-X MATERIAL DID NOT ADHERE TO THE CRANIC THECA AND IT WAS REMOVED EASILY. IT WAS THE OPINION OF THE SURGEON THAT THE PHLOGOSIS (INFLAMMATION) WAS GENERATED BY KRYPTONITE CONSIDERING IT LIKE A MATERIAL EXTRANEOUS TO THE BODY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 KRYPTONITE-X RADIOPAQUE LIQUID BONE COMPLEX BONE CEMENT GXP DOCTOR'S RESEARCH GROUP, INC. KRYP-X-10 10282008

Patients

Seq Age Sex Outcome Treatment
1 UNK